Background {#Sec1}
==========

In 2011, chronic obstructive pulmonary disease (COPD) had a global prevalence of 12% and was the third leading cause of death in the USA \[[@CR1]\]. Oxygen (O~2~) delivery to COPD patients with an acute disease exacerbation remains challenging. High inspired O~2~ concentrations should be used with caution, because COPD patients may breathe with a hypoxic drive \[[@CR2]\]. To avoid carbon dioxide (CO~2~) narcosis, O~2~ must be provided in a controlled fashion with a target saturation of only 88--92% \[[@CR3]\]. This recommendation was studied in a prehospital care setting of 405 patients with COPD exacerbations: When O~2~ was delivered via nasal prongs with a target percentage of oxygen saturation of arterial blood of 88-92%, measured by pulse oximetry (SpO~2~), a significantly lower in-hospital mortality (4% versus 9%, *p* = 0.02) was observed when compared with standard O~2~ delivery using a non-rebreathing mask \[[@CR4]\]. In addition, there were fewer hypercapnic and acidotic episodes in the group with O~2~ delivered via a nasal cannula. Accordingly, the British Thoracic Society recommends three options for oxygen delivery to COPD patients at risk for hypercapnic respiratory failure: (i) Venturi mask 28% at 4 L/min. or Venturi mask 24% at 2-4 L/min. with a target SpO~2~ of 88--92%. (ii) If the SpO~2~ falls below 88%, O~2~ delivery should be changed to a nasal cannula with an O~2~ flow 2--6 L/min. or a simple face mask with an O~2~ flow of 5 L/min. (iii) Increases in partial pressure of carbon dioxide in arterial blood (P~a~CO~2~) or progressive acidotic pH require noninvasive ventilation or intubation and mechanical ventilation \[[@CR5]\]. Non-rebreathing masks may be used in severely hypoxic patients. It is essential to set the O~2~ flow of non-rebreathing masks to 10--15 L/min. in order to avoid CO~2~ rebreathing. Because of the risk of hypercapnic respiratory failure, blood gases must be analyzed every 30--60 minutes. We report the case of a patient with COPD who developed CO~2~ narcosis because of inadequate use of the non-rebreathing mask.

Case presentation {#Sec2}
=================

A 72-year-old, cachectic (height 170 cm, weight 50 kg, BMI 17.3 kg/m^2^) Caucasian man with COPD and a history of smoking had increasing shortness of breath. Pulmonary function testing performed 9 years prior showed a decreased forced expiratory volume in 1 second (FEV~1~) \[38% of predicted, Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 3\], which did not increase after albuterol inhalation. The high total lung capacity and residual volume were consistent with emphysema. On arrival of the emergency medical team at his home, our patient was dyspneic but alert. His vital signs were: blood pressure 150/100 mmHg, heart rate 103 bpm, and SpO~2~ 81%. High-flow O~2~ was supplied at 10 L/min. using a non-rebreathing mask with an O~2~ reservoir bag (Fig. [1](#Fig1){ref-type="fig"}). The SpO~2~ increased to 99% within 20 minutes, and our patient was transported to the emergency department. As it was unknown whether our patient had a hypoxic respiratory drive, O~2~ flow was erroneously limited to 4 L/min. He got increasingly irritated, had no headache, but was no longer oriented to time, place, and person, and became unconscious, gasping for air 2 hours later. His blood pressure was 110/80 mmHg, and the heart rate was 80 bpm. Breath sounds were distant, and his tongue was cyanotic. An arterial blood gas analysis taken shortly after starting bag-valve-mask ventilation showed marked hypercapnia with respiratory acidosis (Table [1A](#Tab1){ref-type="table"}). Noninvasive ventilation was not a possible option \[[@CR6]\]. Our patient was intubated, mechanically ventilated, and received albuterol and ipratropium bromide by inhalation. Methylprednisolone, amoxicillin clavulante plus clarithromycin (for an infiltrate in the right paracardiac region), and low-dose theophylline were administered intravenously. Four hours later, our patient was extubated (Table [1B](#Tab1){ref-type="table"}), and was later transferred to a medical ward. The high P~a~CO~2~ was explained by low tidal volumes and a probably hypoxic ventilatory drive (Table [1C](#Tab1){ref-type="table"}). Because of our patient's worsening dyspnea, he mistakenly received O~2~ at 2 L/min. by the same non-rebreathing mask (Fig. [1](#Fig1){ref-type="fig"}). After a few hours, intensive care unit (ICU) admission was required due to hypotension (75/50 mmHg) and bradypnea (Table [1D](#Tab1){ref-type="table"}). He was re-intubated and mechanically ventilated for 24 hours. Norepinephrine was given to stabilize the blood pressure. An electrocardiogram (ECG) showed a sinus rhythm with right bundle branch block and right ventricular hypertrophy, and the echocardiography documented a chronic cor pulmonale with pulmonary arterial hypertension. Respiratory acidosis improved, and the patient was temporarily extubated (Table [1E](#Tab1){ref-type="table"}). However, aspiration of a pea (removed by bronchoscopy, Fig. [2](#Fig2){ref-type="fig"}) with atelectasis of the right lung again necessitated mechanical ventilation and a tracheostomy. One month after admission, the exhausted patient died of CO~2~ narcosis (Table [1F](#Tab1){ref-type="table"}). An autopsy was not performed.Fig. 1Photograph of a non-rebreathing mask with an oxygen reservoir bag attached. The mask has one unidirectional inspiration valve and two unidirectional expiration valves. The carbon dioxide exhaled by the patient is constantly diluted by a high flow of oxygen delivered to the mask (10--15 L/min.) Table 1Arterial blood gas analyses at different time points during the hospital stayTime point (see text)A, day 1B, day 1C, day 3D, day 4E, day 5F, day 30O~2~ flow rate; mode of administration4 L/min.; non-rebreathing mask2 L/min.; nasal cannula2 L/min.; nasal cannula2 L/min.; non-rebreathing mask2 L/min.; nasal cannula2 L/min.; tracheal cannulapH (7.3--7.4)7.17.37.47.27.47.1P~a~O~2~ (kPa^a^ \[11.1--14.4\])10.910.46.86.08.110.9P~a~CO~2~ (kPa^a^ \[4.7--6.4\])20.09.37.815.88.320.7Bicarbonate (mmol/L \[24--31\])41.037.535.442.736.749.8Base excess (-1.5 to +3.0)3.08.29.19.410.517.7S~a~O~2~ (% \[95.0--99.9\])89.492.584.870.388.694Respiratory rate (L/min. \[12--16\])ND3024Apneic30ND*ND* not determined, *O* ~*2*~ oxygen, *P* ~*a*~ *O* ~*2*~ partial pressure of oxygen in arterial blood, *P* ~*a*~ *CO* ~*2*~ partial pressure of carbon dioxide in arterial blood, *p*H power of hydrogen; negative logarithm of the hydrogen ion concentration, *S* ~*a*~ *O* ~2~ percentage of oxygen saturation of arterial blood^a^To convert kPa to mmHg, multiply by 7.5 Fig. 2Photograph made during bronchoscopy on day 10. A pea is visible in the bronchus to the right laterobasal pulmonary segment

Discussion {#Sec3}
==========

The first two episodes of CO~2~ narcosis (Table [1A, D](#Tab1){ref-type="table"}) were due to near asphyxia and CO~2~ rebreathing because of incorrect use of the non-rebreathing mask by providing insufficient (2--4 L/min.) O~2~ supply. The third episode was due to probable hypoventilation and severe exhaustion (Table [1F](#Tab1){ref-type="table"}).

Assuming a reduced tidal volume \[[@CR7]\] of 200 mL (normal 7 mL/kg body weight = 350 mL) and a respiratory rate of 30/min., our patient's estimated minute ventilation was 6 L/minute (respiratory minute volume \[mL\] = tidal volume \[mL\] × respiratory rate \[1/min.\]. The respiratory minute volume \[mL\] is also the sum of the alveolar ventilation \[mL\] + the dead space ventilation \[mL\]). In high-concentration reservoir masks only an O~2~ flow that exceeds the minute ventilation guarantees a sufficient air supply. Consequently, the reservoir bag of the non-rebreathing mask must not be allowed to deflate by more than one third during inspiration. Our patient's respiratory dead space was 100 mL (2 mL/kg body weight), and the dead space of the mask was 50 mL. The increased dead space (150 versus 100 mL) was relevant for gas exchange; the alveolar ventilation decreased from 3 L/min. to 1.5 L/min., which substantially compromised gas exchange. Furthermore, due to insufficient washout by the low O~2~ flow to the face mask \[[@CR8]\], our patient rebreathed a toxic amount of CO~2~. Our patient was unable to increase his low tidal volume, and an increase in the respiratory rate was insufficient, given the considerable ventilatory dead space.

Jensen *et al.* examined the effect of different oxygen flow rates on ventilation parameters and gas exchange in ten healthy volunteers wearing a simple oronasal face mask (Hudson^®^) without a reservoir bag. Lowering the oxygen supply from 5 to 0 L/min. led to an increase in minute ventilation from 4.8 to 7.5 L/min. due to an increase in tidal volume from 380 to 540 mL with almost no change in respiratory rate. The P~a~O~2~ decreased from 38 to 13 kPa, the S~a~O~2~ from 100% to 96%, while the P~a~CO~2~ remained unchanged. The authors inferred from their results that CO~2~ retention will occur in patients with COPD wearing a simple oronasal face mask with an O~2~ supply set to \< 5L/minute, because these patients cannot increase their tidal volumes \[[@CR8]\].

In severely hypoxemic patients with COPD, O~2~ may be delivered using a non-rebreathing mask with a target O~2~ flow rate of 10--15 L/min. Arterial blood gases must be analyzed regularly. Approximately 13% of patients with COPD admitted with an exacerbation of their disease will develop CO~2~ retention during controlled O~2~ therapy \[[@CR2]\]. In this case, it is important not to stop the O~2~ flow completely because of the risk of rebound hypoxemia \[[@CR9]\]. For a target S~a~O~2~ of 88--92%, an O~2~ supply via nasal cannula with an O~2~ flow rate of 1--2 L/minute is usually sufficient \[[@CR5]\]. If not, either noninvasive or mechanical ventilation must be considered \[[@CR6]\]. Paramedics may safely use low-inspired O~2~ flow (≤4 L/min.) by nasal cannula initially in patients with COPD exacerbations \[[@CR10]\].

Conclusions {#Sec4}
===========

Non-rebreathing masks with O~2~ reservoir bags must be fed with an O~2~ flow exceeding the patient's minute ventilation (\>6--10 L/min.). If not, the amount of oxygen delivered will be too small to effectively increase the arterial O~2~ saturation. Moreover, the risk of CO~2~ rebreathing dramatically increases if the flow of oxygen to a non-rebreathing mask is lower than the minute ventilation, especially in patients with COPD and low tidal volumes. As a consequence, CO~2~ narcosis may develop. Non-rebreathing masks (with O~2~ reservoir bags) must be used cautiously by experienced medical staff and correctly with an appropriately high O~2~ flow of 10--15 L/min. \[[@CR5], [@CR11]\]. Nevertheless, arterial blood gases must be analyzed regularly for early detection of a rise in P~a~CO~2~ in patients with COPD and a hypoxic ventilatory drive. These patients are more safely managed using a nasal cannula with an O~2~ flow of 1--2L/min. or a simple face mask with an O~2~ flow of 5L/min. \[[@CR5]\].
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